Publications Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis Citation Vande Casteele N, Jeyarajah J, Jairath V, Feagan BG, Sandborn WJ. Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1814-1821.e1. doi: 10.1016/j.cgh.2018.10.036. Epub 2018 Oct 26. PMID: 30613004. Abstract Background & aims: Therapeutic drug monitoring might be used to personalize infliximab treatment of patients with ulcerative colitis (UC), although exposure thresholds associated with endoscopic healing are uncertain. We aimed to determine infliximab concentration thresholds associated with endoscopic outcomes during induction and maintenance therapy for patients with UC. Tags ACT-1, ACT-2, Anti-TNF, Colonoscopy, Drug Therapy, Exposure-Based Dosing, Gastrointestinal Agents, Infliximab, Intestinal Mucosa, Pathology, Pharmacokinetics, Therapeutic drug monitoring, therapeutic use, Treatment Outcome, Ulcerative Colitis Read More